StockData
Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc. (PHAT) stock

PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/30
$5.50−0.38 (-6.46%)

Close on Nov 17, 2026Market cap $447.10MP/E –Yield –

Phathom Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Phathom Pharmaceuticals's price to book ratio was 29.9× on Oct 31, 2023, against 5.2× a year earlier. Over the last 3 years it ranged from 2.8× to 46.3×, with a median of 5.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Oct 31, 202329.9×+20.7
2022Jul 29, 20229.2×+3.5
2021Dec 31, 20215.7×+0.2
2020Dec 31, 20205.5×–

More Phathom Pharmaceuticals figures

See a number that looks wrong?